CareDx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade CareDx 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CDNA

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. 

CEO
John W. Hanna, MBA
CEOJohn W. Hanna, MBA
Employees
765
Employees765
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
1998
Founded1998
Employees
765
Employees765

CDNA Key Statistics

Market cap
2.33B
Market cap2.33B
Price-Earnings ratio
21.85
Price-Earnings ratio21.85
Dividend yield
Dividend yield
Average volume
1.18M
Average volume1.18M
High today
$47.58
High today$47.58
Low today
$45.25
Low today$45.25
Open price
$47.04
Open price$47.04
Volume
708.98K
Volume708.98K
52 Week high
$49.76
52 Week high$49.76
52 Week low
$11.27
52 Week low$11.27

Stock Snapshot

With a market cap of 2.33B, CareDx(CDNA) trades at $46.21. The stock has a price-to-earnings ratio of 21.85.

On 2026-08-16, CareDx(CDNA) stock traded between a low of $45.25 and a high of $47.58. Shares are currently priced at $46.21, which is +2.1% above the low and -2.9% below the high.

The CareDx(CDNA)'s current trading volume is 708.98K, compared to an average daily volume of 1.18M.

In the last year, CareDx(CDNA) shares hit a 52-week high of $49.76 and a 52-week low of $11.27.

In the last year, CareDx(CDNA) shares hit a 52-week high of $49.76 and a 52-week low of $11.27.

CDNA News

TipRanks 2d
CareDx Inc Earnings Call Highlights Growth And Risks - TipRanks

...

CareDx Inc Earnings Call Highlights Growth And Risks - TipRanks
Simply Wall St 4d
Does CareDx’s Profit Jump And Higher 2026 Outlook Change The Bull Case For CDNA?

In late July 2026, CareDx, Inc. reported second-quarter revenue of US$131.95 million and net income of US$110.64 million, a shift from a loss a year earlier, an...

Does CareDx’s Profit Jump And Higher 2026 Outlook Change The Bull Case For CDNA?

Analyst ratings

57%

of 7 ratings
Buy
57.1%
Hold
42.9%
Sell
0%

People also own

Based on the portfolios of people who own CDNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.